Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HyperLa: Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training: A Multi-centre Study by the HyperLa Study Group

NCT07721766 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT07721766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07721766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HyperLa: Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training: A Multi-centre Study by the HyperLa Study Group
Lead sponsor
Technical University of Munich
Phase
Not applicable
Overall status
Recruiting
Start date
May 4, 2026
Completion date
December 1, 2026
Enrollment
120 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

glycolysis, healthy volunteers, moderately trainend, muscle hypertrophy